- 関
- interferons, IFNa2b
WordNet
- the 1st letter of the Roman alphabet (同)a
- the blood group whose red cells carry the A antigen (同)type_A, group A
- sequence of a eukaryotic genes DNA that is not translated into a protein (同)noncoding DNA
- a brief introductory passage to a piece of popular music
PrepTutorEJDIC
- answer / ampere
- arsenicの化学記号
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/09/12 17:14:25」(JST)
[Wiki en表示]
Interferon alfa 2b
Clinical data |
MedlinePlus |
a690006 |
Pregnancy
category |
- US: C (Risk not ruled out)
|
Legal status |
- UK: Prescription-only (POM)
- US: ℞-only
|
Routes of
administration |
Subcutaneous, intramuscular |
Identifiers |
CAS Registry Number |
Y |
ATC code |
L03AB05 |
IUPHAR/BPS |
8338 |
DrugBank |
DB00105 Y |
ChEMBL |
CHEMBL1201558 N |
|
N (what is this?) (verify) |
Interferon alfa 2b is an antiviral drug originally discovered in the laboratory of Charles Weissmann at the University of Zurich, developed at Biogen, and ultimately marketed by Schering-Plough under the tradename Intron-A. It has been used for a wide range of indications, including viral infections and cancers.
This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, and malignant melanoma.
Interferon alfa-2b products[1] |
Product |
Manufacturer |
Features |
Special uses |
Alpharona |
Pharmaclon |
|
|
Intron-A/IntronA |
Schering-Plough |
|
|
Realderon |
Teva |
|
|
Reaferon EC |
GNC Vector |
|
|
Reaferon EC-Lipint |
Vector-Medica |
liposomal |
|
Infagel |
Vector-Medica |
ointment |
|
Recolin |
Vector-Medica |
|
|
Altevir |
Bioprocess subsidiary |
liquid, free of HSA |
|
Viferon |
Feron |
suppository or ointment with vitamins C, E |
viral, bacterial, chlamydiosis |
Kipferon |
Alfarm |
combination with IgM, IgA, IgG |
|
Giaferon |
A/S Vitafarma |
|
|
Genferon |
Biocad |
|
|
Grippferon |
Firn-M |
nasal formulation |
influenza |
Opthalamoferon |
Firn-M |
with dimedrol |
eye infections |
Gerpferon |
Firn-M |
with acyclovir, lidocaine ointment |
herpes |
See also
References
- ^ Dmitrij I. Bairamashvili1 and Mikhail L. Rabinovich2* (2007). "Russia through the prism of the world biopharmaceutical market" (PDF). Biotechnol. J 2.
External links
- Product website
- Intron-A Summary of Product Characteristics
- Nagata S, Taira H, Hall A et al. (Mar 1980). "Synthesis in E. coli of a polypeptide with human leukocyte interferon activity". Nature 284 (5754): 316–20. doi:10.1038/284316a0. PMID 6987533.
Cell signaling: cytokines
|
|
By family |
|
|
By function/
cell |
|
|
Index of signal transduction
|
|
Description |
- Intercellular
- neuropeptides
- growth factors
- cytokines
- hormones
- Cell surface receptors
- ligand-gated
- enzyme-linked
- G protein-coupled
- immunoglobulin superfamily
- integrins
- neuropeptide
- growth factor
- cytokine
- Intracellular
- adaptor proteins
- GTP-binding
- MAP kinase
- Calcium signaling
- Lipid signaling
- Pathways
- hedgehog
- Wnt
- TGF beta
- MAPK ERK
- notch
- JAK-STAT
- apoptosis
- hippo
- TLR
|
|
|
Immunostimulants (L03)
|
|
Endogenous |
Cytokines |
Colony-stimulating factors |
- G-CSF
- Filgrastim / Pegfilgrastim
- Lenograstim
- GM-CSF
- Molgramostim
- Sargramostim
- SCF
|
|
Interferons |
- alpha:
- Albinterferon
- Interferon alfa natural
- Interferon alfa 2a / Peginterferon alfa-2a
- Interferon alfa 2b / Peginterferon alfa-2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
- beta:
- Interferon beta natural
- Interferon beta 1a
- Interferon beta 1b
- Interferon gamma
|
|
Interleukins |
|
|
|
Other protein / peptide |
- Growth hormone
- Immunocyanin
- Pegademase
- Prolactin
- Tasonermin
|
|
Other |
- Female sex steroids
- Histamine dihydrochloride
- Poly ICLC
- Vitamin D
|
|
|
Exogenous |
- beta-glucan
- heterocyclic compound
- hydroxyquinoline
- Mifamurtide
- oligopeptides
- Glatiramer acetate
- Thymopentin
- Thymosin α1
- Thymulin
- polyribonucleotide
- Polyinosinic:polycytidylic acid
- thiazolidine
- vaccines
- Bacillus Calmette–Guérin
- Melanoma vaccine
- Sipuleucel-T
|
|
Index of the immune system
|
|
Description |
- Physiology
- cells
- autoantigens
- autoantibodies
- complement
- surface antigens
- IG receptors
|
|
Disease |
- Allergies
- Immunodeficiency
- Immunoproliferative immunoglobulin disorders
- Hypersensitivity and autoimmune disorders
- Neoplasms and cancer
|
|
Treatment |
- Procedures
- Drugs
- antihistamines
- immunostimulants
- immunosuppressants
- monoclonal antibodies
|
|
|
DNA virus antivirals (primarily J05, also S01AD and D06BB)
|
|
Baltimore I |
Herpesvirus |
DNA-synthesis
inhibitor |
TK activated |
Purine analogue |
- guanine (Aciclovir#/Valaciclovir
- Ganciclovir/Valganciclovir
- Penciclovir/Famciclovir)
|
|
Pyrimidine analogue |
- uridine (Idoxuridine
- Trifluridine (+tipiracil)
- Edoxudine)
|
|
|
Not TK activated |
|
|
|
Other |
- Docosanol
- early protein (Fomivirsen)
- Tromantadine
|
|
|
HPV/MC |
- Imiquimod/Resiquimod
- Podophyllotoxin
|
|
Vaccinia |
|
|
Poxviridae |
|
|
|
Hepatitis B (VII) |
- Nucleoside analogues/NARTIs: Entecavir
- Lamivudine
- Telbivudine
- Clevudine
- Nucleotide analogues/NtRTIs: Adefovir
- Tenofovir
|
|
Multiple/general |
Nucleic acid inhibitors |
|
|
Interferon |
- Interferon alfa 2b
- Peginterferon alfa-2a
|
|
Multiple/unknown |
- Ribavirin#/Taribavirin†
- Moroxydine
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Index of viral disease
|
|
Description |
|
|
Disease |
- Systemic
- Cutaneous
- Zoster
- Human papillomavirus
- Zoonotic
- Symptoms and signs
|
|
Treatment |
|
|
|
RNA virus antivirals (primarily J05, also S01AD and D06BB)
|
|
Hepatitis C |
- protease inhibitors
- Asunaprevir†
- Boceprevir
- Faldaprevir†
- Grazoprevir†
- Paritaprevir
- Ritonavir
- Telaprevir
- Simeprevir
- RNA polymerase inhibitors
- NS5A inhibitors
- ACH-3102†
- Daclatasvir
- Deleobuvir§
- Elbasvir†
- Ledipasvir
- MK-3682
- MK-8408
- Samatasvir
- Ombitasvir
- NS5B inhibitor
combinations (Ombitasvir/paritaprevir/ritonavir, Ledipasvir/sofosbuvir)
|
|
Picornavirus |
|
|
Anti-influenza agents |
- adamantane derivatives/M2 inhibitors (Amantadine
- Rimantadine)
- neuraminidase inhibitors/release phase (Oseltamivir
- Zanamivir
- Peramivir, Laninamivir†)
|
|
Multiple/general |
Interferon |
- Interferon alfa 2b
- Peginterferon alfa-2a#
|
|
Multiple/unknown |
- BCX4430
- Ribavirin#/Taribavirin†
- Moroxydine
- Favipiravir
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Index of viral disease
|
|
Description |
|
|
Disease |
- Systemic
- Cutaneous
- Zoster
- Human papillomavirus
- Zoonotic
- Symptoms and signs
|
|
Treatment |
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Development of intron length polymorphism markers in genes encoding diketide-CoA synthase and curcumin synthase for discriminating Curcuma species.
- Kita T1, Komatsu K2, Zhu S2, Iida O3, Sugimura K4, Kawahara N3, Taguchi H5, Masamura N5, Cai SQ6.
- Food chemistry.Food Chem.2016 Mar 1;194:1329-36. doi: 10.1016/j.foodchem.2015.08.034. Epub 2015 Aug 12.
- Various Curcuma rhizomes have been used as medicines or spices in Asia since ancient times. It is very difficult to distinguish them morphologically, especially when they are boiled and dried, which causes misidentification leading to a loss of efficacy. We developed a method for discriminating Curc
- PMID 26471689
- Distinct Expression Patterns of AAV8 Vectors with Broadly Active Promoters from Subretinal Injections of Neonatal Mouse Eyes at Two Different Ages.
- Xiong W1, Cepko C2.
- Advances in experimental medicine and biology.Adv Exp Med Biol.2016;854:501-7. doi: 10.1007/978-3-319-17121-0_67.
- The retinal expression patterns were analyzed following the injection of serotype 8 adeno-associated virus (AAV8) vectors that utilize two broadly active and commonly used sets of transcription regulatory sequences. These include the human cytomegalovirus (CMV) immediate early (IE) enhancer/promoter
- PMID 26427452
- Single-Molecule Live-Cell Visualization of Pre-mRNA Splicing.
- Martin RM1, Rino J1, de Jesus AC1, Carmo-Fonseca M2.
- Methods in molecular biology (Clifton, N.J.).Methods Mol Biol.2016;1358:335-50. doi: 10.1007/978-1-4939-3067-8_22.
- Microscopy protocols that allow live-cell imaging of molecules and subcellular components tagged with fluorescent conjugates are indispensable in modern biological research. A breakthrough was recently introduced by the development of genetically encoded fluorescent tags that combined with fluoresce
- PMID 26463395
Japanese Journal
- Novel intron-containing luciferase genes for quantitative analysis of mRNA levels in transient gene expression assays
- Hayakawa Hideto,Ogura Rieko,Hiratsuka Kazuyuki
- Plant Biotechnology 29(5), 505-509, 2012-12
- NAID 40019545377
- The mtDNA rps3 locus has been invaded by a group ? intron in some species of Grosmannia
- Rudski Shelly M.,Hausner Georg
- Mycoscience 53(6), 471-475, 2012-11
- NAID 40019496158
- Analysis of an intron intervening the SSU rDNA of Chlorella sp. T-24-5, a photobiont of Paramecium bursaria
Related Links
- Learn about INTRON® A — how it works and what life may be like during treatment. Learn about your condition, too. Find information that can help you feel more in control, more confident about making decisions, and better equipped ...
- Intron A, a trademark for a parenteral antineoplastic (interferon alfa-2b, recombinant). Alferon A purified human interferon (IFN), IFN-alfa-n3, which has been used to treat various cancers (leukaemia, melanoma, Kaposi’s sarcoma) and ...
★リンクテーブル★
[★]
[★]
- 関
- adenoviral、adenovirus
[★]
イントロ
- 関
- introduction